<DOC>
	<DOCNO>NCT02014532</DOCNO>
	<brief_summary>The adjunctive use Leukotriene Receptor Antagonist ( Montelukast ) along scale root plan patient chronic periodontitis lead host inflammatory response modulation decrease serum C reactive protein ( CRP ) level . If prove open new vista treatment chronic periodontitis .</brief_summary>
	<brief_title>Role Leukotriene Receptor Antagonists Treatment Chronic Periodontitis</brief_title>
	<detailed_description>A RCT carry check efficacy Montelukast adjunct scale root planing . The patient randomise either test group ( SRP + Montelukast ) control group ( SRP ) . Clinical parameter assess baseline , 3 week 6 week . Serum C-reactive protein level assess baseline , 3 week 6 week .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Leukotriene Antagonists</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>1 . Patients within age group 30 55 year . 2 . Systemically healthy individual . 3 . Patients chronic generalize periodontitis ( moderate severe ) accord Center Disease Control ( CDC ) work group , 2007 criterion 1 . Patients systemic illness ( i.e. , diabetes mellitus , cancer , human immunodeficiency syndrome , bone metabolic disease , disorder compromise wound healing , radiation , immunosuppressive therapy ) , 2 . Smoking , 3 . Chronic alcoholic , 4 . Pregnancy lactation , 5 . Use NonSteroidal AntiInflammatory Drugs ( NSAIDs ) , steroids antibiotic / antimicrobial within January 2012 Jun 2013 , 6 . Confirmed suspected intolerance Montelukast , 7 . Periodontal therapy do within January 2012 Jun 2013 .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Leukotriene receptor antagonist</keyword>
	<keyword>Chronic periodontitis</keyword>
	<keyword>Scaling root planing</keyword>
	<keyword>C- reactive protein</keyword>
</DOC>